Aptevo Therapeutics (APVO) Price/Sales Ratio
Market Cap: $3.51M
Avg Volume: 73.41K
Industry: Biotechnology
Sector: Healthcare
What is Aptevo Therapeutics's Price/Sales Ratio?
- Aptevo Therapeutics's trailing twelve month (TTM) Price/Sales ratio is 0.00.
- Aptevo Therapeutics's annual Price/Sales ratio as of today is 0.00.
- Aptevo Therapeutics's quarterly Price/Sales ratio is 0.00.
What is the Price/Sales Ratio?
The Price/Sales ratio (P/S ratio) is a valuation metric that compares a company's stock price to its revenues. A lower P/S ratio may indicate that a stock is undervalued.
How is the Price/Sales Ratio calculated?
The Price/Sales ratio is calculated by dividing the company's market capitalization by its total sales or revenue. The formula is:
P/S Ratio = Market Capitalization / Total Sales (Revenue)
Related Metrics
Other important metrics to assess Aptevo Therapeutics's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: -0.05
- Quarterly: -0.05
- TTM: -0.03
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 0.26
- Quarterly: 0.26
- TTM: 0.14
- P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: -0.05
- Quarterly: -0.21
- TTM: -0.03
- PEG Ratio (Price/Earnings to Growth Ratio) - measures the company's valuation considering its earnings growth:
- Annual: 0.00
- Quarterly: 0.00
- TTM: 0.00
These metrics provide insights into Aptevo Therapeutics's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Price/Sales Ratio
0.00
Quarterly Price/Sales Ratio
0.00
TTM Price/Sales Ratio
0.00
Aptevo Therapeutics Historical Price/Sales Ratio
Historical P/E Ratio
Historical P/B Ratio
Historical P/C Ratio
Historical PEG Ratio
Aptevo Therapeutics Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Price/Sales Ratio | P/E Ratio | P/B Ratio | P/C Ratio | PEG Ratio |
|---|---|---|---|---|---|
| 2024 | 0.00 | -0.05 | 0.26 | -0.05 | 0.00 |
| 2023 | 0.00 | -4.71 | 6.70 | -6.99 | 0.02 |
| 2022 | 140.59 | 10.26 | 24.36 | -20.83 | -0.08 |
| 2021 | 111.05 | -49.98 | 1122.60 | -62.97 | 1.39 |
| 2020 | 1067.12 | -249.25 | 277.10 | -156.84 | 2.61 |
| 2019 | 2.18 | -1.75 | 5.97 | -1.67 | 0.00 |
| 2018 | 45.83 | -19.69 | 34.77 | -20.56 | -1.74 |
| 2017 | 228.34 | 479.99 | 40.80 | -80.51 | -7.82 |
| 2016 | 50.15 | -16.25 | 36.13 | -49.57 | -0.18 |
| 2015 | 178.21 | -100.95 | 67.57 | -122.80 | -6.28 |
Related Metrics
Explore detailed financial metrics and analysis for APVO.